Elevated  ||| S:0 E:9 ||| FW
transaortic  ||| S:9 E:21 ||| FW
valvular  ||| S:21 E:30 ||| FW
gradients  ||| S:30 E:40 ||| FW
after  ||| S:40 E:46 ||| IN
combined  ||| S:46 E:55 ||| JJ
aortic  ||| S:55 E:62 ||| JJ
valve  ||| S:62 E:68 ||| NN
and  ||| S:68 E:72 ||| CC
mitral  ||| S:72 E:79 ||| JJ
valve  ||| S:79 E:85 ||| JJ
replacement ||| S:85 E:96 ||| NN
:  ||| S:96 E:98 ||| :
an  ||| S:98 E:101 ||| DT
intraoperative  ||| S:101 E:116 ||| JJ
dilemma  ||| S:116 E:124 ||| NN
High  ||| S:124 E:129 ||| NNP
transaortic  ||| S:129 E:141 ||| FW
valvular  ||| S:141 E:150 ||| FW
gradients ||| S:150 E:159 ||| FW
,  ||| S:159 E:161 ||| ,
after  ||| S:161 E:167 ||| IN
combined  ||| S:167 E:176 ||| JJ
aortic  ||| S:176 E:183 ||| JJ
valve  ||| S:183 E:189 ||| NN
and  ||| S:189 E:193 ||| CC
mitral  ||| S:193 E:200 ||| JJ
valve  ||| S:200 E:206 ||| JJ
replacement ||| S:206 E:217 ||| NN
,  ||| S:217 E:219 ||| ,
require  ||| S:219 E:227 ||| VBP
prompt  ||| S:227 E:234 ||| JJ
intraoperative  ||| S:234 E:249 ||| JJ
diagnosis  ||| S:249 E:259 ||| NN
and  ||| S:259 E:263 ||| CC
appropriate  ||| S:263 E:275 ||| JJ
management ||| S:275 E:285 ||| NN
.  ||| S:285 E:287 ||| .
The  ||| S:287 E:291 ||| DT
presence  ||| S:291 E:300 ||| NN
of  ||| S:300 E:303 ||| IN
high  ||| S:303 E:308 ||| JJ
transaortic  ||| S:308 E:320 ||| JJ
valvular  ||| S:320 E:329 ||| JJ
gradients  ||| S:329 E:339 ||| NN
after  ||| S:339 E:345 ||| IN
cardiopulmonary  ||| S:345 E:361 ||| JJ
bypass ||| S:361 E:367 ||| NN
,  ||| S:367 E:369 ||| ,
in  ||| S:369 E:372 ||| IN
this  ||| S:372 E:377 ||| DT
setting ||| S:377 E:384 ||| NN
,  ||| S:384 E:386 ||| ,
can  ||| S:386 E:390 ||| MD
be  ||| S:390 E:393 ||| VB
secondary  ||| S:393 E:403 ||| JJ
to  ||| S:403 E:406 ||| TO
the  ||| S:406 E:410 ||| DT
following  ||| S:410 E:420 ||| JJ
conditions ||| S:420 E:430 ||| NNS
:  ||| S:430 E:432 ||| :
prosthesis  ||| S:432 E:443 ||| JJ
dysfunction ||| S:443 E:454 ||| NN
,  ||| S:454 E:456 ||| ,
left  ||| S:456 E:461 ||| VBD
ventricular  ||| S:461 E:473 ||| JJ
outflow  ||| S:473 E:481 ||| NN
tract  ||| S:481 E:487 ||| NN
obstruction ||| S:487 E:498 ||| NN
,  ||| S:498 E:500 ||| ,
supravalvular  ||| S:500 E:514 ||| JJ
obstruction ||| S:514 E:525 ||| NN
,  ||| S:525 E:527 ||| ,
prosthesis-patient  ||| S:527 E:546 ||| JJ
mismatch ||| S:546 E:554 ||| NN
,  ||| S:554 E:556 ||| ,
hyperkinetic  ||| S:556 E:569 ||| NN
left  ||| S:569 E:574 ||| VBD
ventricle  ||| S:574 E:584 ||| VBN
from  ||| S:584 E:589 ||| IN
administration  ||| S:589 E:604 ||| NN
of  ||| S:604 E:607 ||| IN
inotropes ||| S:607 E:616 ||| NN
,  ||| S:616 E:618 ||| ,
left  ||| S:618 E:623 ||| VBD
ventricular  ||| S:623 E:635 ||| JJ
intracavitary  ||| S:635 E:649 ||| JJ
gradients ||| S:649 E:658 ||| NN
,  ||| S:658 E:660 ||| ,
pressure  ||| S:660 E:669 ||| NN
recovery  ||| S:669 E:678 ||| NN
phenomenon ||| S:678 E:688 ||| NN
,  ||| S:688 E:690 ||| ,
and  ||| S:690 E:694 ||| CC
increased  ||| S:694 E:704 ||| VBD
transvalvular  ||| S:704 E:718 ||| JJ
blood  ||| S:718 E:724 ||| NN
flow  ||| S:724 E:729 ||| NN
resulting  ||| S:729 E:739 ||| VBG
from  ||| S:739 E:744 ||| IN
hyperdynamic  ||| S:744 E:757 ||| JJ
circulation  ||| S:757 E:769 ||| NN
or  ||| S:769 E:772 ||| CC
anemia ||| S:772 E:778 ||| NN
.  ||| S:778 E:780 ||| .
Transesophageal  ||| S:780 E:796 ||| JJ
echocardiography  ||| S:796 E:813 ||| NN
is  ||| S:813 E:816 ||| VBZ
an  ||| S:816 E:819 ||| DT
extremely  ||| S:819 E:829 ||| RB
useful  ||| S:829 E:836 ||| JJ
tool  ||| S:836 E:841 ||| NN
for  ||| S:841 E:845 ||| IN
timely  ||| S:845 E:852 ||| JJ
diagnosis  ||| S:852 E:862 ||| NN
and  ||| S:862 E:866 ||| CC
treatment  ||| S:866 E:876 ||| NN
of  ||| S:876 E:879 ||| IN
this  ||| S:879 E:884 ||| DT
complication ||| S:884 E:896 ||| NN
.  ||| S:896 E:898 ||| .
We  ||| S:898 E:901 ||| PRP
describe  ||| S:901 E:910 ||| VBP
a  ||| S:910 E:912 ||| DT
case  ||| S:912 E:917 ||| NN
of  ||| S:917 E:920 ||| IN
a  ||| S:920 E:922 ||| DT
critically  ||| S:922 E:933 ||| JJ
ill  ||| S:933 E:937 ||| JJ
patient  ||| S:937 E:945 ||| NN
with  ||| S:945 E:950 ||| IN
endocarditis  ||| S:950 E:963 ||| NN
and  ||| S:963 E:967 ||| CC
acute  ||| S:967 E:973 ||| JJ
lung  ||| S:973 E:978 ||| NN
injury ||| S:978 E:984 ||| NN
,  ||| S:984 E:986 ||| ,
who  ||| S:986 E:990 ||| WP
presented  ||| S:990 E:1000 ||| VBD
for  ||| S:1000 E:1004 ||| IN
combined  ||| S:1004 E:1013 ||| JJ
aortic  ||| S:1013 E:1020 ||| JJ
valve  ||| S:1020 E:1026 ||| NN
and  ||| S:1026 E:1030 ||| CC
mitral  ||| S:1030 E:1037 ||| JJ
valve  ||| S:1037 E:1043 ||| JJ
replacement ||| S:1043 E:1054 ||| NN
.  ||| S:1054 E:1056 ||| .
Transesophageal  ||| S:1056 E:1072 ||| JJ
echocardiographic  ||| S:1072 E:1090 ||| JJ
assessment ||| S:1090 E:1100 ||| NN
,  ||| S:1100 E:1102 ||| ,
post-cardiopulmonary  ||| S:1102 E:1123 ||| JJ
bypass ||| S:1123 E:1129 ||| NN
,  ||| S:1129 E:1131 ||| ,
revealed  ||| S:1131 E:1140 ||| VBD
high  ||| S:1140 E:1145 ||| JJ
transaortic  ||| S:1145 E:1157 ||| NNS
valvular  ||| S:1157 E:1166 ||| VBP
gradients  ||| S:1166 E:1176 ||| JJ
due  ||| S:1176 E:1180 ||| JJ
to  ||| S:1180 E:1183 ||| TO
encroachment  ||| S:1183 E:1196 ||| VB
of  ||| S:1196 E:1199 ||| IN
the  ||| S:1199 E:1203 ||| DT
mitral  ||| S:1203 E:1210 ||| JJ
prosthesis  ||| S:1210 E:1221 ||| JJ
strut  ||| S:1221 E:1227 ||| NN
on  ||| S:1227 E:1230 ||| IN
the  ||| S:1230 E:1234 ||| DT
left  ||| S:1234 E:1239 ||| JJ
ventricular  ||| S:1239 E:1251 ||| JJ
outflow  ||| S:1251 E:1259 ||| NN
tract ||| S:1259 E:1264 ||| NN
,  ||| S:1264 E:1266 ||| ,
which  ||| S:1266 E:1272 ||| WDT
was  ||| S:1272 E:1276 ||| VBD
compounded  ||| S:1276 E:1287 ||| VBN
by  ||| S:1287 E:1290 ||| IN
a  ||| S:1290 E:1292 ||| DT
small ||| S:1292 E:1297 ||| JJ
,  ||| S:1297 E:1299 ||| ,
hypertrophied ||| S:1299 E:1312 ||| NN
,  ||| S:1312 E:1314 ||| ,
and  ||| S:1314 E:1318 ||| CC
hyperkinetic  ||| S:1318 E:1331 ||| NNS
left  ||| S:1331 E:1336 ||| VBD
ventricle ||| S:1336 E:1345 ||| VBN
.  ||| S:1345 E:1347 ||| .
Discontinuation  ||| S:1347 E:1363 ||| NN
of  ||| S:1363 E:1366 ||| IN
inotropic  ||| S:1366 E:1376 ||| JJ
support ||| S:1376 E:1383 ||| NN
,  ||| S:1383 E:1385 ||| ,
administration  ||| S:1385 E:1400 ||| NN
of  ||| S:1400 E:1403 ||| IN
fluids ||| S:1403 E:1409 ||| NNS
,  ||| S:1409 E:1411 ||| ,
phenylephrine ||| S:1411 E:1424 ||| NN
,  ||| S:1424 E:1426 ||| ,
and  ||| S:1426 E:1430 ||| CC
esmolol  ||| S:1430 E:1438 ||| VB
led  ||| S:1438 E:1442 ||| VBN
to  ||| S:1442 E:1445 ||| TO
resolution  ||| S:1445 E:1456 ||| NN
of  ||| S:1456 E:1459 ||| IN
the  ||| S:1459 E:1463 ||| DT
high  ||| S:1463 E:1468 ||| JJ
gradients  ||| S:1468 E:1478 ||| NN
and  ||| S:1478 E:1482 ||| CC
prevented  ||| S:1482 E:1492 ||| VBD
further  ||| S:1492 E:1500 ||| JJ
surgery ||| S:1500 E:1507 ||| NN
.  ||| S:1507 E:1509 ||| .
